Business:
Covalent small molecules targeting post-translational modification sites
About:
Covant Therapeutics proclaims expertise in chemistry, proteomics, and deep learning, leveraged in developing covalent therapeutics. Co-founder Ben Ruprecht has over 10 years of expertise in spectrometry-based proteomics and chemoproteomics, acting as head of the Proteomics Platform at Covant.
Senior Analyst, Payroll/Manager, Payroll Tax Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|15 days ago
Associate, Governance Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|42 days ago
Principal, Roivant Health Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|70 days ago
Associate, Roivant Health Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|70 days ago
Director of Pharmacovigilance Systems and Operatio... Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|79 days ago
Vice President of Clinical Operations (Remote) Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|100+ days ago